Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
July 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SILO
Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital first care and research to everyone
July 16, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
HSBC
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
July 16, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
BSEM
Top Realtor in Petaluma, CA, Reflects on Journey from Recession Start in 2010 to Industry Success
July 16, 2024
Via
AB Newswire
Topics
Economy
Product Recall
Exposures
Economy
Legal
Product Safety
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
July 15, 2024
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
BSEM
Trump Shooting Recalls Memories Of Reagan Assassination Attempt: Here's How Markets React To Political Violence
July 15, 2024
Via
Benzinga
Topics
Government
Product Recall
Exposures
Legal
Political
Product Safety
Tickers
DIA
DJT
SPY
CCHR Commends Congressional Action to Prevent Continued Use of Electrical Shocking Device
July 13, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
July 13, 2024
Via
The Motley Fool
Exposures
Product Safety
Tickers
LLY
Bill Gates Recalls Barack Obama's Mission To Capture Osama bin Laden In Pakistan Using Fake Polio Vaccination Campaign: '...A Lot Of Damage Had Been Done'
July 13, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
MSFT
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
July 12, 2024
Via
Benzinga
Exposures
Product Safety
Silk Recalls 2024: What to Know as Plant-Based Milk Recalled Over Listeria Concerns
July 11, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
FCEL
JOBY
KZIA
WMT
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Prepares to Submit Briefing Book to FDA, Looks to Obtain Key Feedback Regarding NDA for CNM-Au8 in ALS
July 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Salmonella Saga: FDA Reportedly Uncovers Years of Contamination at PepsiCo Plant
July 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CHWY
IYK
PEP
XLP
First Choice Neurology Pioneering Neurologists Administer the New FDA-Approved Drug Kisunla
July 11, 2024
Via
PRLog
Exposures
Product Safety
Tickers
LLY
From Chicago Streets to California Politics: A Riveting Memoir of Triumph Over Adversity
July 11, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Surprise Buying Opportunity on This Dividend Aristocrat
July 11, 2024
Via
MarketBeat
Topics
Economy
Product Recall
Exposures
Interest Rates
Legal
Product Safety
Tickers
PEP
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
July 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
Windsor Park: Decades of Sinking Homes and the Path to New Beginnings
July 11, 2024
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
July 11, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
CTXR
TechMediaBreaks – Longeveron Inc.’s (NASDAQ: LGVN) Lomecel-B(TM) Granted RMAT Designation for the Treatment of Mild Alzheimer’s Disease
July 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
Kazia Therapeutics Shares Are Jumping Today: Successful Study For Brain Cancer Treatment
July 10, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
KZIA
FDA Approves Expanded Use Of Arcutis Biotherapeutics' Eczema Drug For Patients As Young As 6 Years
July 10, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ARQT
Why Is Longeveron Stock Soaring On Wednesday?
July 10, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LGVN
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Elected New Board Member at Annual Stockholder Meeting
July 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
Stellantis Recalls More Than 341K Vehicles Over Concerns Of Airbag Non-Deployment, Incorrect Pressure Information On Tire Placard
July 10, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)
July 10, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
CYBN
FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
July 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
XOMA
ZVRA
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
July 09, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
INSP
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study
July 09, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
LEXX
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study
July 09, 2024
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
LEXX
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.